Kedar Upadhye, global CFO of Cipla, says the company has received approval for the Seretide MDI inhaler. This is a market with a $200 million size as Cipla will be the second generics player in the UK ...

Pharmaceutical firm Cipla Ltd on Friday said it is voluntarily recalling six batches of Albuterol Sulfate inhalation aerosol in the US market due to container defect. Cipla Ltd, India's fourth-largest ...